Search results
Found 9282 matches for
An unexpected repair function for neutrophils
30 October 2020
In a collaboration with scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), Kennedy researchers have contributed to the discovery that neutrophils have many more functions in the body than previously thought. This finding suggests that neutrophil tissue-specific plasticity could be exploited in designing new treatments for neutrophil driven diseases, including cancer.
Understanding the physics of the immune response necessitates new technology
23 October 2020
Professor Marco Fritzsche has joined the Kennedy Institute as the Principal Investigator of the Biophysical Immunology Laboratory (BPI), as part of a joint appointment with the Rosalind Franklin Institute. His lab is leading the development of a lattice light sheet microscope that will significantly advance the study of live cells.
CD2 corolla calls T cells to arms
20 October 2020
A team from the University of Oxford has visualised how key cells of the immune system lock onto cancerous or infected cells to destroy them. The work was led by the Mike Dustin’s group at the Kennedy Institute of Rheumatology and experts in colorectal and ovarian cancers from across Oxford and computational biologists at the University of Birmingham.
Likely culprits causing blood vessel lesions in vasculitis identified
19 October 2020
NDORMS researchers identify a subset of immune cells that could be a new therapeutic target to treat inflamed blood vessels in Giant Cell Arteritis (GCA) and other forms of inflammatory vascular disease.
Kennedy researcher receives MRC Clinical Training Fellowship
General
9 October 2020
Dr Rahul Ravindran has been awarded a highly competitive MRC Clinical Research Training Fellowship, following a successful research placement at the Kennedy Institute in 2019.
Research review reveals potential to improve colon cancer treatments
2 October 2020
Researchers at the Kennedy Institute review the growing body of literature on the role of the microbiome in colorectal cancer
IL-22 pathway linked to poor prognosis in colon cancer
18 August 2020
Congratulations to our new Associate Professors
Awards
23 July 2020
The University of Oxford has awarded the title of Associate Professor to Kennedy researchers Tal Arnon and Marco Fritzsche.
Marie Curie Fellowship awarded to Mariana Borsa
10 July 2020
Congratulations to Mariana Borsa for being awarded the Marie Skłodowska-Curie Actions – Individual Fellowship
Reach for the sky
General
8 July 2020
A building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.
Kennedy Professor leads Cellular Life Theme of Reuben College
1 July 2020
Professor Mark Coles was recently appointed to the governing body of the University’s newest graduate college.
Joint cell discovery offers new hope for people with rheumatoid arthritis
29 June 2020
The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.
Sir Marc Feldmann awarded the 2020 Tang Prize in Biopharmaceutical Science
Awards
22 June 2020
Recognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.
NDORMS professor awarded prestigious Carol Nachman prize for Rheumatology
Awards
17 June 2020
Christopher Buckley, Kennedy Professor of Translational Rheumatology at the University of Oxford and Birmingham, has been awarded the 2020 Carol Nachman prize for Rheumatology.
Oxford leads part of major COVID-19 drugs trial
10 June 2020
The Arthritis Therapy Acceleration Programme (A-TAP), led by the Kennedy Institute in Oxford and the Institute of Inflammation and Ageing in Birmingham, provides support for the new CATALYST Trial to investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
New atlas of stromal cells maps out potential for treating human fibrosis
4 June 2020
Research at the Kennedy Institute reveals sub-populations of stromal cells with distinct functions in human fibrotic disease. These findings could inform development of more specific therapies with fewer off-target effects.
Understanding of inflammatory bowel disease moves a step closer
23 May 2020
Published in Science Immunology, researchers at the Kennedy Institute have identified the role of IRF5 in controlling intestinal inflammation.
Dr. Michael Dustin joins Strategic Research Collaboration with Cue Biopharma
14 May 2020
The research will test innovative technology that harnesses the body’s intrinsic immune system to transform the treatment of cancer and autoimmune diseases.
New weapon identified in arsenal against disease
11 May 2020
Researchers in the Dustin Group reveal supramolecular attack particles are autonomous killing entities released from cytotoxic T lymphocytes